Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

NCT00804154 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

45

Enrollment

NIH

Sponsor class

Conditions

Intractable Pain
Palliative Care

Interventions

DRUG: Intrathecal Resiniferatoxin

Sponsor

National Institute of Dental and Craniofacial Research (NIDCR)

Collaborators

[object Object]
[object Object]